escitalopram/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases antidepressant treatment response rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The proportion of responders was significantly greater with citalopram and escitalopram than placebo and the two effect sizes were of similar magnitude.”
Quoted verbatim from Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants.. - Study
- meta-analysis
- Population
- Adults with major depression in placebo-controlled trials of escitalopram (12 trials), eight-week acute treatment, pooled
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants.2012PMID:23167972Permalink
Keep reading
- Everything the graph holds on escitalopram
- Every compound studied against Antidepressant treatment response rate
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45G01D8M5AZXB72R4R86VK9